Pfizer PAC Our Voices. Our Impact. Pfizer PAC and Corporate Political Contributions Report January 2017 – December 2018 Pfizer PAC – Supporting Policies and Policymakers that Put Patients First. A Message from Sally Susman, Chair, Pfizer PAC I am pleased to share our annual political contributions report, which includes a list of candidates and political committees supported either by Pfizer Inc. or the Pfizer PAC from January 1, 2017 through December 31, 2018. Like our Pfizer employees, we are proud that the Pfizer PAC is bipartisan; we contribute to candidates of both political parties and we do not contribute to Presidential candidates. Pfizer PAC and Pfizer Inc supported 2,241 candidates and multiple political committees at all levels of the government during the 2017-2018 election cycle. Of the candidates our PAC supported, 87% were elected or re-elected. Sixty percent of the Pfizer PAC disbursements went to Republicans and 40% went to Democrats. I hope you will take some time to review the report to see which candidates the PAC supported in your state and community. The Biopharmaceutical industry and patients continue to face significant legislative and regulatory challenges, and each election cycle is a new opportunity for lawmakers to either help or hinder patient access to innovative medicines. We are focused on making sure it’s the former. Our elected officials are making difficult choices, including focusing on cost reductions that could fundamentally alter our ability to discover and develop new cures and therapies for those who are counting on us to help make their lives better. Our priority is to help build a constructive discourse in the political and regulatory environment while supporting policies – and policymakers – that put patients first. Those policy priorities include the protection of intellectual property, supporting a patient centric healthcare system that enables access and encourages innovation, protecting patients from unnecessary insurance barriers and counterfeit medicines, protecting Medicare Part D - a program with 90% satisfaction among beneficiaries, and ensuring patients have modern insurance that includes affordable out-of-pocket costs. At the state level, we are working to reduce out-of-pocket costs for patients, reform insurer barriers that delay and deny care, eliminate regulatory and legislative barriers to accessing biosimilars, innovative vaccines and consumer products, and pass civil justice and tax reform legislation. As Pfizer’s PAC Chair, and through my interactions with elected officials, I see first-hand how decisions are made that impact our ability to discover and bring to market innovative medicines and vaccines as well as off-patent medicines that patients and physicians rely on every day. We must ensure our voice is heard so that we can continue to put patients first in everything we do. Thank you for your support, Sally Susman Chair, Pfizer PAC 2 PFIZER PAC Our Voices, Our Impact. What is a PAC? Who Receives Pfizer PAC Contributions? PAC stands for Political Action Committee. A political action Pfizer PAC is nonpartisan. It supports committee is a government-regulated Democrats and Republicans alike. organization that anyone can form From January 2017 through Decmeber to raise money for political campaign 2018, Pfizer PAC supported 2,241 donations. PACs are formed by candidates. True to its nonpartisan individuals, non-profits, and even values, Pfizer PAC is committed to major corporations. support candidates from both political parties who share Pfizer’s vision and How Does Pfizer PAC Work? values for healthcare. When choosing to make a contribution to a candidate, The Pfizer political action committee, the Pfizer PAC considers candidates’ Pfizer PAC, is a nonpartisan views on issues that impact Pfizer and organization that provides its employees as well as the presence opportunities for employees to of Pfizer facilities or employees in the participate in the American political candidate’s district or state. A process. The Pfizer PAC is an complete list of Pfizer PAC and state employee-run organization with a corporate political contributions Steering Committee made up of Pfizer for January 2017 - December 2018 is employees from different divisions included in this report. of the company. All corporate PACs are funded by voluntary employee contributions. Pfizer PAC is no different; it relies on the participation of Pfizer colleagues. 3 Pfizer PAC & Political Contributions Governance Policy Pfizer complies fully with all federal, state, and local laws and reporting requirements governing PAC and corporate political contributions. Pfizer has a Corporate Policy Procedure (#802a) that requires all PAC and corporate political contributions to be compiled and published annually in a report that is made available to employees, shareholders, and the public, and posted on the Company’s website at www.pfizer com in “Lobbying and Political Contributions” under the “About Pfizer” tab within the “Corporate Governance” section. At the end of each Federal cycle (every two years), the Pfizer PAC is audited by Withum, a certified public accounting and advisory firm. Pfizer also requests that trade associations receiving total payments of $100,000 or more from Pfizer in a given year report the portion of Pfizer dues or payments used for expenditures or contributions that, if made directly by Pfizer, would not be deductible under section 162(e)(1)(B) of the Internal Revenue Code. We are disclosing such information received from our trade associations in this report. Pfizer has a PAC Steering Committee comprised of eight colleagues who review and approve all PAC and corporate political contributions on a monthly basis. To ensure adequate representation, Steering Committee members represent different divisions within the Pfizer organization. The PAC Steering Committee evaluates candidates on a basis of their views on issues that impact Pfizer and its colleagues. It also takes note of whether Pfizer facilities or colleagues reside in a candidate’s district or state. In addition, all PAC and corporate contribution requests are shared with the Pfizer Political Contributions Policy Committee for review. The Political Contributions Policy Committee is responsible for governing the Pfizer PAC. Pfizer does not traditionally make contributions to 527 Issue Organizations. If we were asked to make such a contribution, it would have to be reviewed and approved by the Political Contributions Policy Committee and subsequently disclosed in our semi-annual report. Finally, in light of the Supreme Court decision in the Citizens United case, Pfizer has determined that it will not make any direct independent expenditures, a decision which has been discussed at the executive level as well as with the Corporate Governance Committee of our Board. 4 Political Contributions Policy Committee* CHAIR Ken Cole Rod MacKenzie Sally Susman Senior Vice President, Executive Vice President, Executive Vice President, U.S. Government Relations Chief Development Officer, Chief Corporate Affairs Officer Corporate Affairs Global Product Development Group TREASURER Robert Jones Joseph Gruber Senior Vice President, Marc Scarduffa Senior Vice President, U.S. Government Relations Vice President, Global Tax Corporate Affairs U.S. Government Relations & Public Affairs SECRETARY Navin Katyal Barbara Bonfiglio General Manager, Julie Schiffman Assistant General Counsel, Pfizer Sterile Injectables, Vice President, Corporate Governance Innovative Medicines Global Business Analytics, Chief Digital Office Jeff Keisling Senior Vice President, Andrew Schmeltz Chief Information Officer, Global President, Business Technology Pfizer Oncology, Innovative Medicines Kirsten Lund-Jurgensen, PhD Executive Vice President, Susan Silbermann President, Global President, Pfizer Global Supply Pfizer Vaccines, Innovative Medicines Margaret Madden Vice President & Corporate John Young Secretary, Group President, Chief Governance Counsel Chief Business Officer Pfizer PAC Steering Committee* David Blackwell Richard Dudek Senior Director, Vice President, John F. Kelly Research & Development National Sales Vice President, Groton, CT Pfizer Oncology Quality Operations & EHS Itasca, IL Pfizer Global Supply Sheryl Colyer New York, NY Vice President, Sam Gonzalez Human Resources Director, Dennis Ryan New York, NY Pfizer Medical Key Account Manager, New York, NY Internal Medicine Patrick Doyle Innovative Medicines General Manager, Mike Hoffman La Jolla, CA Essential Medicines, Latin America Vice President, New York, NY Global Procurement Peapack, NJ *Members for the 2017 – 2018 election cycle. Members have since changed. 5 Pfizer PAC Our Voices. Our Impact. Political Contributions Recipients January 2017 – December 2018 Pfizer Political Contributions Recipients January 2017 – December 2018 Debt Future State/Office Win Full Name Facility Party District Corp PAC Retirement Election ALABAMA US SENATE Luther Johnson Strange, III R $7,500.00 US HOUSE W Rep. Robert Brown Aderholt R 004 $7,500.00 W Rep. Bradley Roberts Byrne R 001 $1,000.00 W Rep. Michael Dennis Rogers R 003 $1,000.00 W Rep. Terri Andrea Sewell D 007 $5,000.00 GOVERNOR W Gov. Kay E. Ivey R $10,000.00 STATE ATTORNEY GENERAL W AG Steve T. Marshall R $18,000.00 STATE SENATE W Sen. Clyde Chambliss, Jr. R 030 $1,000.00 W Sen. Donnie Chesteen R 029 $1,000.00 W John F. Knight, Jr. D 026 $1,000.00 W Sen. Del Marsh R 012 $2,500.00 W Sen. Jim McClendon R 011 $2,000.00 W Sen. Timothy I. Melson R 001 $1,000.00 W